The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity
The Farnesoid-X Receptor, FXR, is a nuclear bile acid receptor. Its originally described function is in bile acid synthesis and regulation within the liver. More recently, however, FXR has been increasingly appreciated for its breadth of function and expression across multiple organ systems, includi...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/797ddc43b94540508e5e69cc1d28fb8e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:797ddc43b94540508e5e69cc1d28fb8e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:797ddc43b94540508e5e69cc1d28fb8e2021-11-25T17:12:52ZThe Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity10.3390/cells101132062073-4409https://doaj.org/article/797ddc43b94540508e5e69cc1d28fb8e2021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3206https://doaj.org/toc/2073-4409The Farnesoid-X Receptor, FXR, is a nuclear bile acid receptor. Its originally described function is in bile acid synthesis and regulation within the liver. More recently, however, FXR has been increasingly appreciated for its breadth of function and expression across multiple organ systems, including the intestine. While FXR’s role within the liver continues to be investigated, increasing literature indicates that FXR has important roles in responding to inflammation, maintaining intestinal epithelial barrier function, and regulating immunity within the gastrointestinal (GI) tract. Given the complicated and multi-factorial nature of intestinal barrier dysfunction, it is not surprising that FXR’s role appears equally complicated and not without conflicting data in different model systems. Recent work has suggested translational applications of FXR modulation in GI pathology; however, a better understanding of FXR physiology is necessary for these treatments to gain widespread use in human disease. This review aims to discuss current scientific work on the role of FXR within the GI tract, specifically in its role in intestinal inflammation, barrier function, and immune response, while also exploring areas of controversy.Kemp M. AndersonChristopher P. GayerMDPI AGarticleFarnesoid X Receptorintestineinnate immunityinflammationfibroblast growth factorsmall heterodimer proteinBiology (General)QH301-705.5ENCells, Vol 10, Iss 3206, p 3206 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Farnesoid X Receptor intestine innate immunity inflammation fibroblast growth factor small heterodimer protein Biology (General) QH301-705.5 |
spellingShingle |
Farnesoid X Receptor intestine innate immunity inflammation fibroblast growth factor small heterodimer protein Biology (General) QH301-705.5 Kemp M. Anderson Christopher P. Gayer The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity |
description |
The Farnesoid-X Receptor, FXR, is a nuclear bile acid receptor. Its originally described function is in bile acid synthesis and regulation within the liver. More recently, however, FXR has been increasingly appreciated for its breadth of function and expression across multiple organ systems, including the intestine. While FXR’s role within the liver continues to be investigated, increasing literature indicates that FXR has important roles in responding to inflammation, maintaining intestinal epithelial barrier function, and regulating immunity within the gastrointestinal (GI) tract. Given the complicated and multi-factorial nature of intestinal barrier dysfunction, it is not surprising that FXR’s role appears equally complicated and not without conflicting data in different model systems. Recent work has suggested translational applications of FXR modulation in GI pathology; however, a better understanding of FXR physiology is necessary for these treatments to gain widespread use in human disease. This review aims to discuss current scientific work on the role of FXR within the GI tract, specifically in its role in intestinal inflammation, barrier function, and immune response, while also exploring areas of controversy. |
format |
article |
author |
Kemp M. Anderson Christopher P. Gayer |
author_facet |
Kemp M. Anderson Christopher P. Gayer |
author_sort |
Kemp M. Anderson |
title |
The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity |
title_short |
The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity |
title_full |
The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity |
title_fullStr |
The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity |
title_full_unstemmed |
The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity |
title_sort |
pathophysiology of farnesoid x receptor (fxr) in the gi tract: inflammation, barrier function and innate immunity |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/797ddc43b94540508e5e69cc1d28fb8e |
work_keys_str_mv |
AT kempmanderson thepathophysiologyoffarnesoidxreceptorfxrinthegitractinflammationbarrierfunctionandinnateimmunity AT christopherpgayer thepathophysiologyoffarnesoidxreceptorfxrinthegitractinflammationbarrierfunctionandinnateimmunity AT kempmanderson pathophysiologyoffarnesoidxreceptorfxrinthegitractinflammationbarrierfunctionandinnateimmunity AT christopherpgayer pathophysiologyoffarnesoidxreceptorfxrinthegitractinflammationbarrierfunctionandinnateimmunity |
_version_ |
1718412597711077376 |